Literature DB >> 3632301

Nerve growth factor and the concept of neural-epithelial interactions. Immunohistochemical observations in two cases of vasitis nodosa and six cases of prostatic adenocarcinoma.

K DeSchryver-Kecskemeti, K Balogh, K E Neet.   

Abstract

The so-called perineural invasion is a well-recognized, but poorly understood, phenomenon occurring in vasitis nodosa, a benign epithelial proliferation of the vas deferens; such unusually close epithelial-neural interactions also occur, among others, in benign and malignant conditions of the prostate. In the present study, immunoreactive nerve growth factor was found in the epithelium of these organs. This nerve growth factor is thought to possibly play a role in the process of the so-called perineural invasion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3632301

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

1.  Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells.

Authors:  A A Geldof; M A De Kleijn; B R Rao; D W Newling
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells.

Authors:  E T Walch; D Marchetti
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

3.  Urinary nerve growth factor as an oncologic biomarker for prostate cancer aggressiveness.

Authors:  Michael A Liss; Adam Gordon; Blanca Morales; Kathryn Osann; Douglas Skarecky; Achim Lusch; Frank Zaldivar; Thomas E Ahlering
Journal:  Urol Oncol       Date:  2014-04-29       Impact factor: 3.498

4.  The expression and localisation of beta-nerve growth factor (beta-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation.

Authors:  A B Paul; E S Grant; F K Habib
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.